Amphastar Pharma (AMPH) Reports Q3 Loss of $0.01/Share

Amphastar Pharma (NASDAQ: AMPH) reported Q3 EPS of ($0.01), versus ($0.07) reported last year. Revenue for the quarter came in at $63.9 million, versus $59.7 million reported last year.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Morgan Stanley Downgrades Sands China Ltd. (1928:HK) (SCHYY) to Equalweight
• Citi sees this stock as primary lithium demand beneficiary, upgrades to Buy